Isomorphic Labs

Isomorphic Labs is a drug discovery company launched in the United Kingdom in November 2021. The company will continue the research done by AI lab DeepMind,[1] a subsidiary of Alphabet Inc. The company aims to use artificial intelligence for drug discovery.[2][3][4]

ReferencesEdit

  1. ^ Shead, Sam. "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Retrieved August 4, 2022.
  2. ^ Shead, Sam (November 5, 2021). "Google-parent Alphabet has set up a new lab that will use A.I. to try to discover new drugs". CNBC. Archived from the original on November 5, 2021. Retrieved November 9, 2021.
  3. ^ Crist, Ry (November 4, 2021). "Alphabet launches Isomorphic Labs, an AI-driven drug discovery startup". CNET.
  4. ^ Coldeway, Devin (November 4, 2021). "Isomorphic Labs is Alphabet's play in AI drug discovery". TechCrunch.

External linksEdit